NUI Galway Access Programme Annual Awards Ceremony

NUI Galway Access Programme Annual Awards Ceremony-image

Monday, 5 December 2011

NUI Galway recently presented 85 certificates to students for successful completion of the Access courses during the academic year 2010/2011, both on campus and in Outreach Centres in Clifden and Ballinasloe.   Also receiving awards were 55 Access students who graduated with degrees in Arts, Commerce, Law, Engineering and Nursing in 2011. A further 18 students who received post-graduate diplomas in Education, Health, Arts and Business Studies and post-graduate degrees in Marketing, Social Work, Community Development and Law were also acknowledged.  In addition, eight students who received postgraduate diplomas and degrees in 2010 were acknowledged at the ceremony.   In the last ten years, 390 graduates and 133 post-graduates have been admitted to NUI Galway through its Access Programme.  The ceremony was to mark the achievement of those inspirational students and to commend all on their perseverance, dedication and hard work.    The function of the NUI Galway Access Programme is to address and respond appropriately to the issues of equality of access, equity of life long opportunities and responding to the issues of rural (and to a lesser extent, urban) social exclusion in the Border, Midland and Western Region and County Clare. All elements of the access programmes have important initiatives designed to give everyone a chance to benefit from third level education.    -ENDS-

>> Read full story about NUI Galway Access Programme Annual Awards Ceremony

Leading Anti-Child Slavery Campaigner to Speak at NUI Galway

Leading Anti-Child Slavery Campaigner to Speak at NUI Galway-image

Thursday, 1 December 2011

James Kofi Annan was sold into slavery in Ghana when he was six years old. He comes to NUI Galway on Wednesday, 7 December, to share his story and continue his campaign against child slavery. He will deliver a public talk at 1pm at an event organised by the University’s Irish Centre for Human Rights and the organisation Frontline Defenders. Like most of his other 11 siblings James was sold as a slave, at the tender age of six. He was sent to work in the fishing industry on Lake Volta in Ghana where small children are used to do heavy work with the nets and are sent down to free the nets if they become snagged. He recalls being beaten every day. After seven years he managed to set himself free but he wasn’t welcome back either in his family or in his village, where he was seen to have disobeyed his father. From then on he was on his own. James educated himself by becoming friendly with the children who were attending the local kindergarden school and used their books to teach himself to read and write. James eventually was able to complete his university education and got himself a job with Barclay's Bank. However he could not leave his memories of slavery behind and set up a new organisation called Challenging Heights to help other child slaves like him. “James’s story is compelling and his campaigning and support for child slaves is outstanding. Estimates of a staggering 27 million people in slavery today, many of whom are children, should give us all pause for thought. The blatant disregard for human rights and humanity shown by modern day slavery or human trafficking, must be challenged around the world”, said Professor Ray Murphy of NUI Galway’s Irish Centre for Human Rights. Because James challenges the very profitable status quo he is vilified and attacked and receives death threats on a daily basis by email, text and by phone. Despite the threats and the danger, James Kofi Annan refuses to cease his work to free the victims of child slavery and to end the practice in Ghana. Asked why he chooses to do this dangerous work he replies, “I had nothing left to lose – I had already lost everything I had to lose as a child.” James’s organisation Challenging Heights helps children escape slavery and rebuild their lives by providing them with shelter, rehabilitation and education. All are welcome to this free event at 1pm on Wednesday, 7 December, in the Huston School of Film at NUI Galway (opposite the Cathedral).   -ends-

>> Read full story about Leading Anti-Child Slavery Campaigner to Speak at NUI Galway

November 2011

Prestigious Scholarship for NUI Galway Economics Student

Prestigious Scholarship for NUI Galway Economics Student-image

Wednesday, 30 November 2011

Mohit Agrawal, an NUI Galway economics student, has been awarded one of the most prestigious scholarships in the world, a Rhodes Scholarship to study economics at Oxford University. Mohit is currently studying for an MA in Economic Policy Evaluation and Planning at NUI Galway and plans to begin his studies in Oxford in September 2012. Born and raised in West Lafayette, Indiana, in the US, Mohit enrolled in NUI Galway during September 2011, after being awarded a George J. Mitchell Scholarship, allowing him to do a postgraduate degree at any university on the island of Ireland. Mohit chose the NUI Galway programme because he said it enabled him to further his major career goal, to combine a background in mathematics and politics to help craft economic policy. Mohit completed his undergraduate degree in mathematics and computer science at Princeton University in the United States. Mohit’s interests and achievements extend well beyond the classroom. At Princeton, for example, he was a prominent member of ‘Engineers Without Borders’ and served as the manager of a project to build a library in Ghana. He is interested in politics and has contributed to debates at the Literary and Debating Society in NUI Galway and has also written several articles for the student newspaper SIN including some insightful pieces on the recent Presidential election. The Head of the Economics Discipline at the J.E. Cairnes School of Business and Economics, NUI Galway, Professor John McHale, described Mohit’s achievement at winning a Rhodes Scholarship as a fantastic testimony to his outstanding intellectual ability: “We were very pleased that Mohit chose the economic policy evaluation programme at NUI Galway for his Mitchell Scholarship. Mohit has been a wonderful addition to the economics discipline at this University where he has helped countless undergraduate students as a tutor for one of our main undergraduate courses as well as contributing in lectures and seminars. I have no doubt that Mohit will do extraordinary well in his future career and I am especially pleased that Mohit had decided to focus his career on economics with a special emphasis on economic policy.” ENDS

>> Read full story about Prestigious Scholarship for NUI Galway Economics Student

Irish Universities Celebrate First Intake of Malaysian Students to New Medical Programme

Irish Universities Celebrate First Intake of Malaysian Students to New Medical Programme-image

Wednesday, 30 November 2011

NUI Galway and UCC recently celebrated the first intake of Malaysian students on a twinned medical degree programme. The medical programme is offered by both universities in partnership with the Allianze University College of Medical Sciences (AUCMS), Kapala Batas, in northern Malaysia.   2011 sees the first intake of 100 students, 50 studying at NUI Galway and 50 at UCC. The students will study medicine for the first two and a half years of their degree in Ireland and then go on to complete the remainder of their five-year degree in Malaysia. The partners will deliver a five-year medical programme, under the approval of medical councils in each country. On successful completion, those students who commenced their studies in Galway will be awarded the NUI Galway degree of MB, BAO, BCh*.   NUI Galway and UCC each have a strong tradition of Malaysian students coming to completing their full medical degree over five years. The new partnership however is the outcome of discussions which began in 2005 when the Ministry of Health in Malaysia approached the Irish universities, seeking to develop sustainable Malaysia-based medical education capacity into the future. The Cooperation Agreement which underpins the partnership, was signed in Penang in January 2009. This initiative shifts the clinical training of the students to their home country. However they will still obtain an Irish medical qualification to be approved and accredited by the professional accrediting authorities of Ireland and Malaysia.   The recent Foundation Day event in UCC was officially launched by the Minister of State for Training and Skills, Ciaran Cannon, and attended by the Irish and Malaysian partners, dignitaries from both counties and by the NUI Galway and UCC students.   Speaking at the launch in UCC, Professor Gerard Loftus, Dean of the College of Medicine, Nursing and Health Sciences at NUI Galway, said: “The programme is a very exciting augmentation of the strong tradition we have in the education of Malaysian medical students over the years.  The Malaysian Government recognises that our Malaysian students achieve high clinical standards. I am particularly pleased also that the many very able and committed people who have worked on this project from the outset back in 2005 are here today, when all their efforts come to fruition.”   Current NUI Galway student, Mohamad Sharifudin Dzulkefli said: “Studying in two institutes of higher learning in Ireland and Malaysia really gives us a lot of advantages in terms of knowledge as well as experience. NUI Galway has a lot to offer for the AUCMS students. Gaining basic medical knowledge in Ireland and applying it during the clinical years back in Malaysia gives us the upper hand in the medical field.”   -ENDS-

>> Read full story about Irish Universities Celebrate First Intake of Malaysian Students to New Medical Programme

Ceolchoirm Spleodrach in Áras na Gaeilge

Ceolchoirm Spleodrach in Áras na Gaeilge-image

Thursday, 1 December 2011

Beidh Ceolchoirm am lóin ar siúl ar an Luan, 5 Nollaig, ón 1-2i.n. i dTéatar Uí Chearbhalláin in Áras na Gaeilge in OÉ Gaillimh. Is mic léinn ón gcúrsa Dioplóma sna Dána: Cóiriú agus Stáitsiú an Cheoil Thraidisiúnta a chuirfidh an ceolchoirm speisialta seo i láthair.  Tá an cúrsa á reáchtáil sa Spidéal ag Acadamh na hOllscolaíochta Gaeilge i gcomhar le Stiúideo Cuan. Meascán spéisiúil a bheas ann a chlúdóidh réimse leathan ceoil, idir seoidíní traidisiúnta, ceol nua-chumtha, amhránaíocht agus, dár ndóigh, ríleanna, poirt agus pólcaí spleodracha, spraoiúla.   Is ó chian agus ó chóngar a tháinig na ceoltóirí agus na hamhránaithe seo le chéile mar aon ghrúpa amháin agus dá réir snítear tionchair agus stíleanna éagsúla lena chéile ina gcuid ceoil. Tá roinnt mhaith ceolchoirmeacha déanta acu mar ghrúpa. Ó thosaigh siad le chéile i mí Meán Fómhair i mbliana rinne siad ceolchoirm lóin in Acadamh na hOllscolaíochta Gaeilge ar an gCeathrú Rua agus i seanscoil Shailearna. Ní le ceol amháin a bhíonn siad ag plé ar an gcúrsa seo, áfach, mar go mbíonn siad ag tabhairt faoi ghnéithe teicniúla an cheoil chomh maith. Chuige sin rinne siad clár raidió a thaifead sa stiúideo.  Is é Seán Ó Flatharta, Oifigeach Teanga agus Cultúir, OÉ Gaillimh, atá ag eagrú na hocáide seo i gcomhar le Marianne Ní Chinnéide, Riarthóir Aonad na dTaibhealaíon.  Ní bheidh aon táille ar an doras. Tuilleadh eolais le fáil ó: Marianne Ní Chinnéide, Acadamh na hOllscolaíochta Gaeilge, OÉ Gaillimh ag 087 9080194 nó, nó Seán Ó Flatharta, Oifigeach Teanga agus Cultúir, ag 091 493518 nó -Críoch-

>> Read full story about Ceolchoirm Spleodrach in Áras na Gaeilge

Irish Clinical Researchers Open New Study for Rare but Devastating Cancer

Irish Clinical Researchers Open New Study for Rare but Devastating Cancer-image

Tuesday, 29 November 2011

A new clinical study has opened in Ireland for a rare but devastating type of bone marrow cancer. Irish patients with advanced myelofibrosis will have access to a new study of combined oral medications for their disease.  Frank Giles, Professor of Cancer Therapeutics at NUI Galway and Trinity College Dublin, is leading the study with Eibhlin Conneally, Consultant Haematologist at St James’s Hospital, Dublin. The Irish study is being run in conjunction with centers in France, Italy, and the UK and patients may be enrolled at either Galway University Hospitals or St James’s Hospital.  The study involves a combination of Ruxolitinib, manufactured by Novartis, along with another pill that also targets the abnormal pathways that drive myelofibrosis. This news comes within weeks of Ruxolitinib becoming the first and only product approved for this disease by the US Food and Drug Administration (FDA).  Myelofibrosis is a life-threatening cancer of the bone marrow that results in bone marrow failure because the normal spaces in which blood cells are formed become progressively filled with fibrous tissue. In an attempt to maintain normal blood cell counts, the body then begins to make these cells in abnormal sites including the liver and spleen. In turn, these can then become enlarged and painful. Patients not alone are at risk from marrow failure, but in some patients, myelofibrosis changes into a particularly aggressive form of acute leukemia.  According to Professor Frank Giles, who is also Director of the HRB Clinical Research Facility Galway, a joint venture between Galway University Hospitals and NUI Galway: “We are delighted to finally have our first effective therapy for patients suffering from advanced myelofibrosis. This is a significant positive advance in treatment for these patients. We are very pleased to be able to offer this study to patients here in Ireland, especially as Ruxolitinib has just been approved in the US. We hope that approval in Europe will happen soon but in the interim we have an opportunity to build on this, our first broadly effective therapy for a very debilitating illness, and hopefully offer even better therapy with a combination of medications in the near future.” Ruxolitinib is specifically directed at an abnormally active enzyme or kinase that has been recently defined as a key driver of myelofibrosis. “This kinase, called Jak-2, has emerged as a key target for therapy in myelofibrosis”, said Dr Conneally. “It is a central driver of the disease and inhibiting its function with Ruxolitinib directly improves many patients’ symptoms and reduces their spleen swelling. It is the latest big success in our move away from non-specific cell-killing drugs towards safer, more targeted drugs that are really directed at the fundamental drivers of cancer.” Professor Giles, who has been involved with the development of both of the drugs  being combined in the study, said: “Success in anti-cancer therapies are increasingly driven by a continuous process which involves pre-clinical scientists unlocking the puzzles of what actually makes a cancer cell behave differently from its normal counterpart. Once you have mapped the cancer process, you can define a cancer cell’s key vulnerabilities which leads you to relatively selective targets. Next steps are the creation and testing of drugs or other approaches directed at these targets that will  alter cancer cell behaviour in terms of either killing it or forcing it to behave more like a normal cell. Once these approaches are available to our patients, we return to pre-clinical science to refine and improve anti-cancer therapy, for example, by combining agents with different targets as we are doing on this study.” He concluded: This ‘bench-to-bedside-to-bench’ process has allowed not only the development of Ruxolitinib but allowed us to develop logical ‘next-wave’ potential therapies for patients with myelofibrosis. Collaborations over the last decade between scientists around the world have led to Ruxolitinib being available. Collaborations within Ireland and with our European colleagues have allowed us to offer this study in such a timely manner to Irish patients – a very encouraging template for future success.” -ends-

>> Read full story about Irish Clinical Researchers Open New Study for Rare but Devastating Cancer

Science & Technology Festival Exhibition Attracts 24,000 Visitors

Science & Technology Festival Exhibition Attracts 24,000 Visitors-image

Monday, 28 November 2011

The 2011 Galway Science and Technology Festival Exhibition, part of Discover Science’s National Science Week, was held on the NUI Galway campus last Sunday and attracted 24,000 visitors. The event was officially opened by the European Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn and guest speakers included Dr James Browne, President of NUI Galway, Mayor of Galway City Cllr Hildegarde Naughton and Mr Tom Hyland, Festival Chairman. The European Commissioner commented, “It is a great pleasure for me to welcome everyone to the 2011 Galway Science & Technology Festival Exhibition. The foundation and nurtuing of this festival took vision and dedication and its existence is thanks to the vision of Noel Treacey whose brain-child it is. His work and that of strong supporters like Dr Jim Browne and Tom Hyland as well as many of the companies, educational institutes and researchers, have made this a festival of which to be very proud. For the past two weeks over thousands of young people have taken part in the Festival and engaged with scientists and researchers, asking questions and really getting in touch with science and technology. These young people are the scientists and innovators of tomorrow, and events like this festival are very important in stimulating their curiousity. As a former teacher, I know very well the importance of capturing a child’s imagination at an early age. This is especially important in the case of science and technology, since they pervade almost every aspect of modern life. In today’s economic climate it is more important than ever to ensure that young people are equipped with the skills that they need to succeed. And we need science and technology to get our economy back on track.” The event ran extremely well with up to 100 volunteers, which included students from the Dominican College Secondary School, NUI Galway and members of the public, who provided information and directions to families attending the 80 interactive exhibition stands and the various shows and workshops throughout the University campus. Families and children enjoyed an array of colourful stands including Medtronic who demonstrated how blood pumps around the body, Boston Scientific’s amazing stand with a large stent for children to examine, SAP provided a First Lego League, Hewlett Packard with the help of sixth class students from Briarhill School explained Cloud Computing while other amazing stands were hosted by CISCO, Covidien Avaya and Lake Region. The Galway Enterprise Board stand included local company Starlight and a new App “Ireland: Are we there Yet” by local developer Ann Brehony.  The stands allowed children and adults alike to participate in experiments, watch demonstrations and discuss ideas with researchers. Lots more interatactive exhibitions took place from NUI Galway, GMIT, Marine Institute and many more. A lego competition sponsored by Smyth’s Toys Superstore was in huge demand and accommodated over 300 eager technic lego builders while the 5ft tall Buzz Light Year made of Lego was on loan from Smyth’s for the day was a huge hit with hundreds of children. Sue McGrath’s Chemistry Show was seen by 1,000 people, the Mad Scientist entertained and excited young children about science while Robert Hill explained the Outerworld in his own amazing and engaging way. The RCX Mindstorm lego workshop was in huge demand and Magic Mathworks demonstrated a great way of engaging with maths.  Kitchen Chemistry ran shows throughout the day and educated visitors on how to conduct experiments in the kitchen using regular household products while Bubble Magic had the audience screaming with excitement creating huge bubbles and filling them with smoke. One of the major successes of the Exhibition was a total of 18 Primary and Secondary Schools encompassing 350 students exhibiting their own brilliant science and technology projects while many other students took part by participating with the international companies and helped them demonstrate their products. The opportunity for these young people to attend and work at the Exhibition and engage with the public is of enormous experience for them. Festival Chairman, Tom Hyland commented, “Special thanks must go to the Volunteers who helped in running the event so smoothly and allowing families enjoy their day out. The prebooking system of shows worked wonderfully and really helped people plan their day and those without tickets were also accommodated. I would also like to take this opportunity to thank our main sponsor Medtronic and all other sponsors and the multi-national companies who have agreed to take part in our Mentoring Program where 11 different companies participating in this initiative will visit schools over the next few months and talk to the students about their subject choices, give practical career advice and share their work experience. I would also like to thank NUI Galway for providing the campus facilities to host this truly wonderful event.” Mr Hyland also presented special awards on behalf of the Festival Committee to Brother Niall of the Patrician Brothers with the 2011 Galway Science & Technology Person of the Year Award for his commitment to the Festival over the 14 years and an award to 12-year old sixth class whizz kid Harry Moran from Westport on becoming the world’s youngest app developer of Pizzabot based on a pizza shooting red sauce at slices of salami which he developed in one month. Visit to view some of the photos and videos captured during the Festival Exhibition.ends

>> Read full story about Science & Technology Festival Exhibition Attracts 24,000 Visitors

New Website Watches Galway’s Weather

New Website Watches Galway’s Weather-image

Monday, 28 November 2011

Come rain or shine, a new website showing the current weather conditions in Galway is now available to the general public. The site uses real-time data collected by a weather station at NUI Galway to show temperature, humidity, pressure, wind, rain and sunshine.   Behind the project is the Informatics Research Unit for Sustainable Energy (IRUSE) at NUI Galway, under the leadership of Dr Marcus Keane. IRUSE focuses on achieving the goal of energy efficient buildings. In order to support ongoing and future research activity, IRUSE installed an automated weather station at NUI Galway.   Information from the weather station now appears in real-time on a website thanks to students of the HDip / MSc in Software Design and Development. Colin Divily from Corofin, Co Galway and Naomi Ono, originally from Japan, implemented the website through a collaboration with the Discipline of Information Technology. They were supported by Johann Ott, Magdalena Hajdukiewicz and other members of the IRUSE group.   Dr Marcus Keane explains: “The website displays the live weather data, as well as 12-hour and monthly trends and provides essential data for the research carried out at the University. With the weather being such a constant topic of conversation for everyone in this country, we thought it only right to share this data with the general public.”   The weather station was installed in June 2010 on the roof of the Concourse building on campus. The data loads to the new website every minute from all of the sensors, except for rainfall which is reported hourly.   As well as for IRUSE’s research, the weather station is also used as part of teaching for the Energy Systems Engineering degree programme at NUI Galway.   -ends-

>> Read full story about New Website Watches Galway’s Weather

BioInnovate Ireland Recruiting for Fellowship Programme

BioInnovate Ireland Recruiting for Fellowship Programme-image

Thursday, 24 November 2011

BioInnovate Ireland is now seeking Expressions of Interest for its medical device innovation Fellowship programme. This programme is modelled on the prestigious and internationally-recognised Biodesign programme offered at Stanford University, California.  The recruitment of eight Fellows to work in two elite multidisciplinary teams is now underway. These two teams will focus on a specific clinical area, identifying unmet needs, inventing solutions to meet those needs and implementing the solutions, and mapping a route to commercialisation to enable these solutions to enhance patient care. The Fellowship teams will complete an intensive five week training period, commencing in August 2012, before spending two months of clinical immersion working with top surgeons and medical staff in numerous hospitals around Ireland. The Fellowship teams will then focus on inventing and implementing solutions to address specific problems for the remainder of this 10 month programme. According to BioInnovate Ireland Programme Director, Dr Mark Bruzzi from NUI Galway: “The BioInnovate Ireland Programme offers a unique opportunity for individuals to come together to work in teams to develop novel solutions that impact patient care, and gain access to a network of industry, academic and clinical leaders to guide their solutions from concept to commercialisation.” The Fellowship Programme is full-time, stipend supported and the next programme will commence on 1 August, 2012. In addition to the Fellowship Programme, there are two BioInnovate classes open to postgraduate students of the BioInnovate Academic Partners which include NUI Galway, University of Limerick, Dublin City University, Royal College of Surgeons Ireland and University College Cork.  The BioInnovate class will be mentored by, and work with the Fellows on the newly identified clinical needs.  Marie Travers, a current Galway BioInnovate Fellow, said: “The experience so far is exciting. I feel very privileged to have been able to access experts, patients and clinicians as part of the research. I see great potential for identifying innovations for patient care.” The BioInnovate Fellowship teams are multi-disciplinary and eligible applicants should have a background in medicine, engineering, technology or business. Applicants with a postgraduate degree or relevant professional experience are particularly welcome.  Medical and surgical registrars or specialist registrars with an interest in innovation and improving patient care through technological advancements are also encouraged to apply for the Fellowship. Candidates will be assessed for their leadership potential, interest in technology innovation, demonstrated potential for creativity and invention, and ability to work in a team. For an Expression of Interest form or further details contact Clodagh Barry, BioInnovate Programme Manager at NUI Galway, on 091 494212 or                                                                                                                                                                                                                                              -ENDS-

>> Read full story about BioInnovate Ireland Recruiting for Fellowship Programme

Study Calls Sodium Intake Guidelines into Question

Study Calls Sodium Intake Guidelines into Question-image

Wednesday, 23 November 2011

For years, doctors have warned that too much salt is bad for your heart. Now a new study co-led by an NUI Galway clinical researcher suggests that both high and low levels of salt intake may put people with heart disease or diabetes at increased risk of cardiovascular complications.   The study, published in the Journal of the American Medical Association (JAMA), found that moderate salt intake is associated with the lowest risk of cardiovascular events, whereas higher intake of sodium was associated with an increased risk of stroke, heart attack and other cardiovascular events while low intake was associated with an increased risk of cardiovascular death and hospitalisation for congestive heart failure.   The research was co-led by Professor Martin O’Donnell, Professor of Translational Medicine, NUI Galway and Dr Salim Yusuf, Population Health Research Institute (PHRI) at McMaster University in Canada and Hamilton Health Sciences. Professor O’Donnell is also Associate Director of the HRB Clinical Research Facility at NUI Galway and University Hospital Galway.   “This research addresses an important population health issue – the association between sodium (salt) intake and cardiovascular disease,” said NUI Galway’s Professor O’Donnell. “This area has become topical again, with the recent publication of another paper in JAMA reporting an association between low-sodium intake and cardiac death. In general, previous observational studies have either reported a positive association, no association or an inverse association between sodium intake and heart disease and stroke. This has resulted in a lot of controversy. Our study is the first to report a J-shaped association between sodium intake and cardiovascular disease, which may explain why previous studies have found different results.”   Compared with moderate sodium excretion (between 4 to 5.99 grams per day), the researchers found that sodium excretion of greater than 6-7 grams per day was associated with an increased risk of all cardiovascular events, and sodium excretion of less than 3 grams per day was associated with an increased risk of cardiovascular death and hospitalisation for congestive heart failure.   The findings call into question current guidelines for salt intake, which recommend less than 2.3 grams (or 2,300 mg) per day. The guidelines are mostly based on previous clinical trials that found blood pressure is lowered modestly when sodium intake is reduced to these levels (which was also found in the present study), but there are no large studies looking at whether such low levels of sodium intake reduce the incidence of heart attacks and stroke. Clarifying the optimal daily intake of sodium is particularly important in patients with established heart disease, as they may be especially vulnerable to the cardiovascular effects of very high- and low-salt intake and are most likely to receive recommendations on restricting sodium in their diets, the authors concluded.   “Our research confirms the association between high sodium intake and increased risk of cardiovascular disease, which emphasizes the importance of salt reduction in those consuming high-sodium diets (over 6-7g per day) and the importance of efforts to reduce sodium content of many high-salt manufactured foods. However, our study, together with other recent studies, raises uncertainty about whether those with moderate/average sodium intake should reduce their intake further. The only way to resolve this uncertainty is with a large randomized controlled trial that determines whether reducing moderate sodium intake to lower levels results in lower rates of heart disease and stroke. While we accept there are challenges to conducting such trials, they are required urgently given their public health implications’ said Professor O’Donnell.   For the observational study, the researchers examined 28,880 people at increased risk of heart disease from the ONTARGET and TRANSCEND trials, which were conducted from 2001-2008. The researchers estimated 24-hour urinary sodium and potassium excretion from a morning fasting urine sample. During follow-up, over 4,500 cardiovascular events occurred making this the most powerful study examining the relationship between sodium excretion (which is a surrogate measure of sodium consumption), as well as potassium excretion and cardiovascular events. Extensive and careful statistical analytic methods were used to determine the association of urinary sodium and potassium with cardiovascular events – heart attack, stroke, hospitalisation for congestive heart failure and death.   In addition to the sodium findings, the researchers found higher urinary potassium excretion was associated with lower stroke risk. They concluded this is a potential intervention that merits further evaluation for stroke prevention.   -ends-

>> Read full story about Study Calls Sodium Intake Guidelines into Question

<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 > >>

Press member?

Visit our press centre

Connect & share